EX-10.5 6 dex105.htm CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENT, MARK A. SIRGO CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENTConfidentiality and Intellectual Property Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionThis CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENT (this “Agreement”) is entered into effective for all purposes as of August 24, 2004 by Mark A. Sirgo (“Employee”) in favor of BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”). As used herein, the term “Company” includes BioDelivery Sciences International, Inc. and its subsidiaries, including Arius Pharmaceuticals, Inc.
CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENTConfidentiality and Intellectual Property Agreement • August 26th, 2004 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledAugust 26th, 2004 Company Industry JurisdictionThis CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENT (this “Agreement”) is entered into effective for all purposes as of August 24, 2004 by Andrew L. Finn (“Employee”) in favor of BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”). As used herein, the term “Company” includes BioDelivery Sciences International, Inc. and its subsidiaries, including Arius Pharmaceuticals, Inc.
CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENTConfidentiality and Intellectual Property Agreement • August 26th, 2004 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledAugust 26th, 2004 Company Industry JurisdictionThis CONFIDENTIALITY AND INTELLECTUAL PROPERTY AGREEMENT (this “Agreement”) is entered into effective for all purposes as of August 24, 2004 by Mark A. Sirgo (“Employee”) in favor of BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”). As used herein, the term “Company” includes BioDelivery Sciences International, Inc. and its subsidiaries, including Arius Pharmaceuticals, Inc.